Medtronic, Inc. Buys Imaging Systems Assets of Breakaway Imaging

LOUISVILLE, Colo.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT - News) announced today it has exercised its option to acquire the O-arm® Imaging System assets of Massachusetts-based Breakaway Imaging, LLC. The acquisition brings the O-arm Imaging System into a broad portfolio of image guided surgical solutions within the Navigation business at Medtronic.

The financial terms of the agreement, which is expected to close in June, are not being disclosed.

"The O-arm represents an important step forward in image-guided surgery for Medtronic's customers and their patients," said Jim Cloar, vice president and general manager of the Navigation business at Medtronic. "It will be an essential component in expanding the adoption of minimally invasive spine surgeries and opens the possibility for novel therapies which we believe are the wave of the future."

The O-arm Imaging System, with a breakable gantry and flat screen detector, provides multi-dimensional surgical imaging. It provides surgeons with 3-D images, as well as multi-plane 2-D, and fluoroscopic imaging. It is intended for use in orthopedic surgical procedures and is in use in more than 20 locations worldwide. The O-arm Imaging System received FDA clearance in 2005.

About the Medtronic's Navigation Business

Medtronic Navigation is the world leader in intraoperative Computer Assisted Surgery technologies with its full line of StealthStation® systems. StealthStation combines MRI, CT, or fluoroscopy with optical or proprietary AxiEM(TM) electromagnetic tracking systems to provide real-time visualization of surgical instruments overlaid on a computer-generated rendition of the patient. Medtronic Navigation has more than 2,000 systems installed worldwide to serve a wide range of medical disciplines including, cranial, spinal, orthopedic and ENT surgical applications.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.

Contact: Medtronic, Inc. Public Relations: Bert Kelly, 901-344-0614 or Investor Relations: Jeff Warren, 763-505-2696

Source: Medtronic, Inc.

Back to news